Treatment Advances

February 13, 2025

Read the clinical trial updates on a promising treatment combination that uses epcoritamab, rituximab, and lenalidomide. 

February 11, 2025

Explore glofitamab, a promising treatment for relapsed/refractory follicular lymphoma, offering fewer side effects and longer remission.

February 04, 2025

Discover how CAR T-cell therapy (tisagenlecleucel) performs in real-world follicular lymphoma patients with promising outcomes and safety.

December 31, 2024

Review new data presented at ASH about nemtabrutinib, a once-daily, noncovalent, reversible BTK inhibitor. Clinical trials ongoing and recruiting patients.

November 19, 2024

Learn insights about how certain treatment combinations and a new scoring system impacted people with low-grade follicular lymphoma.

October 29, 2024

If you are a person with advanced-stage follicular lymphoma who is starting their first treatment, learn how certain therapy options compare.

August 13, 2024

Learn about R-CHOP, a chemoimmunotherapy regimen used to treat follicular lymphoma. Understand its effectiveness and what to expect during treatment.

July 22, 2024

Is age just a number? Dr. Julio Chavez shares multicenter findings on how CAR T therapy can be effective in those 80 and older.

July 17, 2024

Discover insights from Dr. Ryan Jacobs on AZD0486, a new bispecific antibody for relapsed or refractory lymphoma patients.

May 21, 2024

Learn about lisocabtagene maraleucel, a new CAR-T therapy option for adults with relapsed or refractory follicular lymphoma, a type of non-Hodgkin lymphoma.